What is Wellinks?
Wellinks is dedicated to empowering individuals with COPD to live fuller lives by providing a personalized, virtual-first management system. Addressing COPD, the third leading cause of death by disease in the U.S., Wellinks aims to overcome traditional healthcare barriers. Their system offers virtual pulmonary rehabilitation, health coaching, and remote monitoring via connected devices and a user-friendly app. The company, based in New Haven, Connecticut, is guided by a team of experienced digital health professionals.
How much funding has Wellinks raised?
Wellinks has raised a total of $44.8M across 3 funding rounds:
Private Equity
$795K
Series B
$19M
Series C
$25M
Private Equity (2016): $795K, investors not publicly disclosed
Series B (2019): $19M led by HighCape Capital
Series C (2021): $25M supported by The Morningside Group, Connecticut Innovations, Stonehenge Capital, HighCape Capital, and Benslie
Key Investors in Wellinks
The Morningside Group
Morningside Group is a private equity and venture capital firm founded in 1986, known for its entrepreneurial investment professionals with deep industry knowledge, focusing on making strategic investments.
HighCape Capital
HighCape Capital is a growth equity fund established in 2013, specializing in assisting innovative Life Sciences companies with their transition to successful organizations, particularly in sectors like Connected Health and Biotechnology.
Connecticut Innovations
Connecticut Innovations is Connecticut's strategic venture capital arm and investment agency, providing financing and strategic guidance to innovative companies within the state, with a focus on sectors including biosciences.
What's next for Wellinks?
The recent major strategic investment signifies a pivotal moment for Wellinks, likely enabling the company to accelerate its product development, expand its market reach, and further enhance its virtual care platform. This capital infusion is expected to bolster its efforts in providing accessible, evidence-based COPD management solutions, potentially leading to broader adoption and improved patient outcomes in the digital health sector.
See full Wellinks company page
